Literature DB >> 9842777

Poor P50 suppression among schizophrenia patients and their first-degree biological relatives.

B A Clementz1, M A Geyer, D L Braff.   

Abstract

OBJECTIVE: This study's goal was to replicate the finding that family members of schizophrenia patients show poor P50 suppression during a paired-click auditory evoked response paradigm.
METHOD: The paired-click paradigm was used to test 44 schizophrenia patients, 60 of their clinically unaffected first-degree relatives, and 45 normal subjects. Two clicks (83 dB[A] over a 60-dB[A] white noise background) separated by 500 msec were presented 60 times to all subjects. P50 responses to the first and second clicks were selected from the digitally filtered data by using standard methods and the Cz recording site.
RESULTS: The schizophrenia patients had smaller P50 responses to click 1 than either their relatives or the normal subjects; the patients and their relatives, who did not significantly differ, had larger P50 responses to click 2 than the normal subjects. Schizophrenia patients had worse P50 suppression than either their family members or the normal subjects; the patients' family members had worse P50 suppression than the normal subjects.
CONCLUSIONS: Family members of schizophrenia patients have worse P50 suppression than normal subjects. To the authors' knowledge, this is the first demonstration independent of the group associated with the University of Colorado that schizophrenia patients' family members have poor P50 suppression. This result is intrinsically important, perhaps especially because a recent report suggests genetic linkage of poor P50 suppression to the cholinergic receptor's alpha7 nicotinic subunit.

Entities:  

Mesh:

Year:  1998        PMID: 9842777     DOI: 10.1176/ajp.155.12.1691

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  64 in total

Review 1.  Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder?

Authors:  Craig M Powell; Tsuyoshi Miyakawa
Journal:  Biol Psychiatry       Date:  2006-06-15       Impact factor: 13.382

Review 2.  Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia.

Authors:  David Potter; Ann Summerfelt; James Gold; Robert W Buchanan
Journal:  Schizophr Bull       Date:  2006-02-09       Impact factor: 9.306

3.  Failure to find P50 suppression deficits in young first-episode patients with schizophrenia and clinically unaffected siblings.

Authors:  O M de Wilde; L J Bour; P M Dingemans; J H T M Koelman; D H Linszen
Journal:  Schizophr Bull       Date:  2007-02-07       Impact factor: 9.306

4.  Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder.

Authors:  L Elliot Hong; Gunvant K Thaker; Robert P McMahon; Ann Summerfelt; Jill Rachbeisel; Rebecca L Fuller; Ikwunga Wonodi; Robert W Buchanan; Carol Myers; Stephen J Heishman; Jeff Yang; Adrienne Nye
Journal:  Arch Gen Psychiatry       Date:  2011-08-01

5.  P50 suppression in children with selective mutism: a preliminary report.

Authors:  Yael Henkin; Maya Feinholz; Miri Arie; Yair Bar-Haim
Journal:  J Abnorm Child Psychol       Date:  2010-01

6.  Are auditory-evoked frequency and duration mismatch negativity deficits endophenotypic for schizophrenia? High-density electrical mapping in clinically unaffected first-degree relatives and first-episode and chronic schizophrenia.

Authors:  Elena Magno; Sherlyn Yeap; Jogin H Thakore; Hugh Garavan; Pierfilippo De Sanctis; John J Foxe
Journal:  Biol Psychiatry       Date:  2008-05-09       Impact factor: 13.382

7.  Impairment in Mismatch Negativity but not Repetition Suppression in Schizophrenia.

Authors:  Brian A Coffman; Sarah M Haigh; Tim K Murphy; Dean F Salisbury
Journal:  Brain Topogr       Date:  2017-05-17       Impact factor: 3.020

Review 8.  Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men.

Authors:  Ann Olincy; Karen E Stevens
Journal:  Biochem Pharmacol       Date:  2007-07-17       Impact factor: 5.858

9.  Sensory gating disturbances in the spectrum: similarities and differences in schizotypal personality disorder and schizophrenia.

Authors:  Erin A Hazlett; Ethan G Rothstein; Rui Ferreira; Jeremy M Silverman; Larry J Siever; Ann Olincy
Journal:  Schizophr Res       Date:  2014-12-05       Impact factor: 4.939

10.  Auditory processing in schizophrenia during the middle latency period (10-50 ms): high-density electrical mapping and source analysis reveal subcortical antecedents to early cortical deficits.

Authors:  Victoria M Leavitt; Sophie Molholm; Walter Ritter; Marina Shpaner; John J Foxe
Journal:  J Psychiatry Neurosci       Date:  2007-09       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.